New drug : sumatriptin & naproxen
Genetic Engineering News - The Leading Publication in Biotechnology:
"POZEN Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of Trexima(TM), the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology (TM), and naproxen sodium, in a single tablet for the acute treatment of migraine."
MY REACTION:
I have used sumatriptin successfully in the past. I look forward to trying this new combo.
"POZEN Inc. announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of Trexima(TM), the proposed brand name for the combination of sumatriptan succinate, formulated with RT Technology (TM), and naproxen sodium, in a single tablet for the acute treatment of migraine."
MY REACTION:
I have used sumatriptin successfully in the past. I look forward to trying this new combo.
posted by Ron King at 6:10 PM
0 Comments:
Post a Comment
<< Home